7812
M. Radi´c Stojkovi´c, I. Piantanida / Tetrahedron 64 (2008) 7807–7814
3. Conclusions
(m, 2H, PhOCO), 7.78–7.83 (m, 2H, phen-H2, phen-H3), 8.23 (dd,1H,
phen-H9, J7–9¼2.0 Hz, J9–10¼9.0 Hz), 8.41 (d, 1H, phen-H4, J3–4
¼
In conclusion, it is important to stress that none of the pre-
viously known bis-phenanthridinium analogues showed such
linker-length dependent switch of the DNA/RNA binding mode.
Obviously a fine interplay between intramolecular aromatic stack-
ing and DNA/RNA intercalation combined with the potential of
hydrogen bonding interactions (urea) could have a dramatic impact
on the interaction of small molecule with DNA/RNA. Together with
previously shown recognition of polynucleotides by modified
phenanthridines3,10,12,23 and related compounds, the results pre-
sented here add significantly to the information pool available for
the design of DNA/RNA selective small molecules. In addition, 6 and
7 are, to the best of our knowledge, the first phenanthridine-based
intercalators able to differentiate between A–U(T) and G–C base
pairs by sign of fluorimetric response.
7.5 Hz), 8.64 (d, 1H, phen-H7, J7–9¼1.6 Hz), 8.74 (d, 1H, phen-H1,
J1–2¼7.5 Hz), 8.86 (d, 1H, phen-H10, J9–10¼9.0 Hz), 10.82 (s, 1H, NH);
13C NMR (DMSO-d6)
d/ppm: 18.83(CH3), 115.44 (phen-H7), 121.68
(phen-H4); 122.22 (Ph); 123.02 (phen-H1); 123.82; 124.42 (phen-
H10), 124.92, 125.60 (Ph), 127.19 (phen-H9), 128.83, 129.03 and
129.41 (phen-H2 and phen-H3), 129.86 (Ph), 133.81, 139.81, 150.49,
151.91, 160.28. IR (KBr)
n
(cmꢁ1): 3425.33, 3240.17, 3109.02,
3066.59, 3041.52, 2921.94, 2854.44, 2671.21, 2370.34, 2345.27,
2023.18, 1944.10, 1735.81, 1625.94, 1566.08, 1531.37, 1488.94,
1448.43, 1371.29, 1321.14, 1292.21, 1234.35, 1193.85, 1176.49,
1070.41, 1026.05, 844.76, 784.97, 754.11, 717.47, 682.75, 557.39,
414.67, 316.30. Anal. Calcd for C21H19N2O3Cl (C21H16N2O2$H2O$
HCl): C, 65.88; H, 5.00; N, 7.32. Found: C, 65.95; H, 4.92; N, 7.37.
Furthermore, due to the capability of urea substituents to form
transition metal complexes,35 which are in this work combined
with phenanthridine fluorophores, compounds 4–7 could be of
great interest for researchers in the fields of inorganic chemistry
and biochemistry. Moreover, preliminary results of our current
studies point toward promising antiproliferative activity of urea–
phenanthridinium compounds toward human tumor cell lines.
4.1.3. 1-(6-Methylphenanthridin-8-yl)-3-[2-(3-(6-methyl-
phenanthridin-8-yl)ureido)ethyl] urea trihydrate (4)
Phenyl-6-methylphenanthridin-8-yl carbamate (3) (0.206 g,
0.627 mmol) was dissolved in dimethyl formamide (3 ml). To this,
K2CO3 (0.087 g, 0.627 mmol) and 1,2-diaminoethane (0.020 ml,
0.018 g, 0.298 mmol) were added. The reaction was stirred at 60–
80 ꢂC for 3–4 h and then at room temperature overnight. Upon
addition of water into the reaction mixture, a white precipitate was
formed and filtered off. The crude product was recrystallized from
methanol to give 0.092 g of a pale yellow solid (58%). Mp 297 ꢂC; 1H
4. Experimental
4.1. Synthesis
NMR (DMSO-d6) d/ppm: 2.88 (s, 6H, CH3), 3.34–3.35 (m, 4H, CH2),
6.40–6.42 (m, 2H, NH), 7.56–7.66 (m, 4H, phen-H2, phen-H3), 7.90–
4.1.1. 40-(Phenyloxycarbonyl)aminobiphenyl-2-yl-acetamide (2)
N,N-Dimethylaniline (1.15 ml, 1.1 g, 9.07 mmol) was added to
a
7.95 (m, 4H, phen-H4, phen-H9), 8.42 (d, 2H, phen-H7, J7–9¼1.3 Hz),
8.58 (d, 2H, phen-H1, J1–2¼7.4 Hz), 8.65 (d, 2H, phen-H10, J9–10
¼
stirred solution of 40-aminobiphenyl-2-yl-acetamide (1.14 g,
8.9 Hz), 9.06 (s, 2H, NH); 13C NMR (DMSO-d6)
d/ppm: 24.25 (CH3),
5.04 mmol) in anhydrous ethanol (25 ml). To the resulting mixture
a solution of phenyl chloroformate (0.925 ml, 0.947 g, 6.05 mmol)
in ethanol (2 ml) was added dropwise and the reaction was carried
out under reflux for 2 h. Subsequently, the solvent was evaporated
under reduced pressure, the remaining solid was dissolved in ethyl
acetate (20 ml), resulting solution washed with water (2ꢀ20 ml)
and crude product was obtained by evaporation of solvent under
reduced pressure. The product was purified by recrystallization
from dichloromethane–petroleum ether to give 1.51 g of brown-
gray crystals (86%).
41. 06 (–(CH2)2–), 113.86 (phen-H7), 123.12 (phen-H1), 123.76
(phen-H9), 124.58 (phen-H10), 124.76, 127.46, 127.58 and 128.73
(phen-H2, phen-H3), 130.15 (phen-H4), 141.43, 143.65, 156.79,
159.16; IR (KBr)
n
(cmꢁ1): 3315.39, 3064.66, 2939.30, 2362.63,
2345.27, 1635.52, 1591.16, 1562.23, 1529.44, 1483.15, 1463.86,
1379.00, 1325.00, 1299.93, 1263.28, 1228.57, 1149.49, 1116.70,
1008.70, 993.27, 950.84, 865.97, 837.04, 761.83, 723.25, 642.25,
622.96, 540.03, 518.81, 464.81, 405.02, 364.52, 329.80, 295.09. Anal.
Calcd for C32H34N6O5 (C32H28N6O2$3H2O): C, 65.96; H, 5.88; N,
14.43. Found: C, 66.15; H, 5.77; N, 14.59.
Mp¼183 ꢂC; 1H NMR (DMSO-d6)
d/ppm: 1.83 (s, CH3, 3H), 7.16–
7.28 (m, 5H, biphenyl, 3H, PhOCO), 7.36–7.40 (m, 1H, biphenyl, 2H,
PhOCO), 7.50–7.51 (s, 2H, biphenyl), 9.15 (s, 1H, NHCOCH3), 10.27 (s,
4.1.4. 1-(6-Methylphenanthridin-8-yl)-3-[6-(3-(6-methyl-
phenanthridin-8-yl)ureido)hexyl] urea trihydrate (5)
1H, NH); 13C NMR (DMSO-d6)
d
/ppm: 23.02 (CH3), 118.40, 121.85,
125.39, 125.77, 127.03, 127.34, 129.20, 129.40, 130.05, 133.59, 134.89,
136.07, 137.73, 150.53, 151.70, 168.57; IR (KBr)
(cmꢁ1): 3454.26,
The product (5) was synthesized as described for 4, starting from
phenyl-6-methylphenanthridin-8-yl carbamate (3) (0.273 g,
0.832 mmol), 1,6-diaminohexane (0.046 g, 0.396 mmol), K2CO3
(0.115 g) in dimethyl formamide (7 ml). The product was then
recrystallized from methanol to yield 0.157 g of a pale yellow solid
n
3394.47, 3238.24, 3172.67, 3093.59, 3041.52, 2937.37, 2856.37,
2790.79, 2362.63, 2335.62, 2219.90, 1951.82, 1930.60, 1733.88,
1666.37, 1608.51, 1589.23, 1483.15, 1446.51, 1407.93, 1321.14,
1298.00, 1228.57, 1157.20, 1068.49, 1022.20, 1010.63, 916.20, 835.12,
811.97, 796.54, 756.04, 719.40, 663.46, 561.24, 507.24, 466.74,
379.95, 329.80, 287.37. For X-ray structure see Ref. 36.
(68%). Mp 287–288 ꢂC; 1H NMR (DMSO-d6)
d/ppm: 1.30–1.44 (m, 8H,
CH2), 2.81 (s, 6H, CH3), 3.08–3.11 (m, 4H, N–CH2), 6.27 (t, 2H, NH,
JNH–CH2¼5.5 Hz), 7.51–7.58 (m, 4H, phen-H2, phen-H3), 7.81 (dd, 2H,
phen-H9, J7–9¼2.0 Hz, J9–10¼8.9 Hz), 7.87 (d, 2H, phen-H4, J3–4
¼
¼
7.98 Hz), 8.34 (d, 2H, phen-H7), 8.53 (d, 2H, phen-H1, J1–2
4.1.2. Phenyl-6-methylphenanthridin-8-yl carbamate
8.2 Hz), 8.60 (d, 2H, phen-H10, J9–10¼9.0 Hz), 8.88 (s, 2H, NH); 13C
hydrochloride hydrate (3)
NMR (DMSO-d6) d/ppm: 23.01 (CH3), 26.14 and 29.73 (–(CH2)4–),
40-(Phenyloxycarbonyl)aminobiphenyl-2-yl-acetamide
(2)
39.09 (N(–CH2–)2), 112.26 (phen-H7), 121.84 (phen-H1), 122.32
(phen-H9), 123.32 (phen-H10), 123.46, 125.96, 126.16, 126.30, and
127.42(phen-H2, phen-H3),128.83(phen-H4),140.24,142.28,155.19,
(0.97 g, 2.80 mmol) was dissolved in phosphorus oxychloride
(4.1 ml) and heated at 100 ꢂC for 1 h. The reaction mixture was
poured into ice water to give a brownish oil, which was upon
stirring converted into yellow precipitate. The resulting mixture
was slowly neutralized by additions of 5 M NaOH, the solid was
filtered off, washed with water and dried. After recrystallization
from methanol, the pure product (3) was obtained as a yellow
powder or crystals (0.81 g, 88%). Mp 228–229 ꢂC; 1H NMR (DMSO-
157.89; IR (KBr)
n
(cmꢁ1): 3325.03, 3105.17, 3056.95, 2925.80,
2864.08, 2364.55, 2339.48, 1942.18, 1888.17, 1643.23, 1560.30,
1475.44, 1438.79, 1380.93, 1359.72, 1296.07, 1245.92, 1203.49,
1114.77, 1010.63, 946.98, 875.62, 862.12, 823.54, 757.97, 700.11,
653.82, 621.03, 540.03, 520.74, 466.74, 430.09, 393.45, 358.73,
335.59, 316.30, 273.87. Anal. Calcd for C36H42N6O5 (C36H36N6O2$
3H2O): C, 67.69; H, 6.63; N, 13.16. Found: C, 67.41; H, 6.63; N, 13.13.
d6) d/ppm: 3.11 (s, 3H, CH3), 7.21–7.24 (m, 3H, PhOCO), 7.38–7.41